MAY 16, 2020 11:07 AM PDT

Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection

WRITTEN BY: Amanda Mikyska

Jeffery Schweitzer, MD, PhD and lead author of the study elaborates on the research methods and hopes for stem cell technology in the future. 

 

Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that avoids rejection by the patient's body, a significant limitation of stem cell therapy.  The experiment was only conducted in one Parkinson's patient, but researchers hope the results will open the door for a larger sample size.  

Stem cells have not "differentiated," meaning they have not taken the form of a specific cell type, such as a skin cell or a nerve cell.  Stem cells give rise to other undefined cells, which either become stem cells or differentiate.  Over the past decade, the technology to use stem cells as personalized therapy has evolved rapidly.  For example, in Multiple Sclerosis (MS) research, the hope is to swap out immune cells that are attacking the patient's own neurons with immune cells, grown from stem cells, that will not attack the neurons.  

On May 13, 2020, MGH released the study taking stem cells from one patient's skin to replace his own dopaminergic neurons lost during his Parkinson's progression.  Dopaminergic neurons produce the majority of the body's dopamine. Parkinson's is associated with tremor and a decline in fine motor skills because the nerve cells do not have enough dopamine to transmit signals between the muscles and the brain.  This study differs from other stem cell research because stem cells typically originate from a bank of stem cells, not the patient's own body.  Though cell banks have greater control over what characteristics the cells have, the patient's body often rejects the transplant.

So far, the 69-year-old patient has responded well to the stem cell transplant.  His body accepted the stem cells, which have reproduced and matured into dopaminergic neurons. Researchers associated with the study say the results are encouraging but emphasize that it was only a single patient test.

The National Institute of Health, McLean Hospital, and MGH, primarily funded the study, but the patient at the center of the study also contributed to the funding.  The researchers worked with the MGH Institutional Review Board to clear all ethical hurdles. 

 

Sources: Schweitzer et. al., ScienceDaily, Mayo Clinic, Harvard Stem Cell Institute

About the Author
  • Amanda graduated for the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
FEB 24, 2020
Genetics & Genomics
FEB 24, 2020
Circular RNAs May Play a Role in Psychiatric Disorders
The genome contains the sequences for many genes that code for proteins. There are also regions and chemical tags that h ...
MAR 20, 2020
Neuroscience
MAR 20, 2020
The Little Things Matter: The Mental Impact of Social Distancing
Image: Metropolitian State University of Denver The COVID-19 pandemic has caused social interactions, resources, and mos ...
APR 11, 2020
Neuroscience
APR 11, 2020
COVID-19 Affects Brain in 36% Patients
A study from China has found that stroke, an altered sense of consciousness and other neurological issues are relatively ...
APR 25, 2020
Neuroscience
APR 25, 2020
Autoimmune Protein May Cause OCD
Researchers from Queen Mary University in London have discovered a specific autoimmune protein that may cause OCD-relate ...
MAY 11, 2020
Cell & Molecular Biology
MAY 11, 2020
3D Cell Culture Model Suggests Herpes Can Cause Alzheimer's
Alzheimer's is a common form of dementia that affects as many as 5.5 million Americans and the incidence is increasing a ...
MAY 26, 2020
Neuroscience
MAY 26, 2020
Alzheimer's Gene Doubles Risk of Severe COVID-19
Researchers from the University of Exeter, England, and the University of Connecticut have found that people carrying fa ...
Loading Comments...